Summer 2025
Lab automation: New Modalities
More visitors, more exhibitors and more new product launches at SLAS Europe in Hamburg.
Highlights included the latest developments in CRISPR automation, toxicity and phenotypic screening in human 3D cell aggregates and the presentation of a completely new protease-resistant and highly specific oral drug class.
In this Focus:
- Finding new leads and modalities automatically
- Spiroligomer molecules: advancing drug design
- Remote controls for immunotherapies